Combination of anlotinib and gemcitabine promotes the G0/G1 cell cycle arrest and apoptosis of intrahepatic cholangiocarcinoma in vitro.

Shanshan FanYang GeJian LiuHeshu LiuRui YanTianbo GaoXiaona FanZeru XiaoGuangyu An

Published in: Journal of clinical laboratory analysis (2021)

The combination of anlotinib and gemcitabine can increase the anti-tumor effect and may be a potential therapeutic drug regimen in a clinical setting.

Keyphrases

cell cycle arrest
cell death
pi k akt
locally advanced
signaling pathway
oxidative stress
cell proliferation
squamous cell carcinoma
radiation therapy
emergency department
adverse drug